Preparation, characterization, and evaluation of miconazole- cyclodextrin complexes for improved oral and topical delivery

Journal of Pharmaceutical Sciences

Volumn 87, Issue 4, 1998, Pages 425-429

  Tenjarla, Srini ^a   Puranajoti, Porranee ^c   Kasina, Ram ^c   Mandal, Tarun ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 2 HYDROXYPROPYL GAMMA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; GAMMA CYCLODEXTRIN; HYDROXYETHYL BETA CYCLODEXTRIN; MICONAZOLE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CADAVER; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ANALYSIS; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; ELECTRON MICROSCOPY; FEMALE; FREEZE DRYING; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SKIN PENETRATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET SPECTROSCOPY;

EID: 0031950153     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970361l     Document Type: Article

References (28)

1. Jawetz, E. Antifungal Agents. In Basic & Clinical Pharmacology, 5th ed.; Katzung, B. G., Eds.; Norwalk, Connecticut: Appleton & Lange, 1992; Chapter 48, pp 667-673.
2. Bennett, J. E. Antimicrobial agents: Antifungal agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed.; Gilman, A. G., Goodman, L. S., Rall T. W., Nies, A. S., Taylor, P., Eds.; McGraw-Hill Inc., Health Professions Division: New York, 1993; Chapter 50, pp 1165-1181.
3. Saag, S. M.; Dismukes, E. W. Azole antifungal agents: Emphasis on new triazoles. Antimicrobial Agents Chemother. 1988, 32, 1-8.
4. Martindale, W. Antifungal Agents. In The Extra Pharmacopoeia / Martindale, 30th ed.; Reynolds, E. F., Parfitt, K., Parsons, A. V., Sweetman, S. C., Eds.; The Council of the Royal Pharmaceutical Society of Great Britain, the Society's Department of Pharmaceutical Sciences, Pharmaceutical Press: London, 1993; pp 315-332.
5. Vanden Bossche, H. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action. Current Topic Med. Mycol. 1985, 1, 313-351.
6. Pershing, K. L.; Corlett, J.; Jorgensen, C. In vivo pharmacokinetics and pharmacodynamics of topical ketoconazole and miconazole in human stratum corneum. Antimicrobial Agents Chemother. 1994, 38, 90-95.
7. Bagnarello, A. G.; Lewis, L. A.; McHenry, M. C. Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N. Engl. J. Med. 1977, 296, 497-499.
8. Bononi, L. J. Beta-cyclodextrin miconazole complex and beta-cyclodextrin econazole complex and their use as medical fungicides. Eur. Pat. Appl. 1988, pp 19.
9. Mura, P.; Liguori, A.; Bramanti, G.; Bettinetti, G.; Campisi, E.; Faggi, E. Improvement of dissolution properties and microbiological activity of miconazole and econazole by cyclodextrin complexation. Eur. J. Pharrn. Biopharm. 1992, 38 (3), 119-123.
10. Hostetler, J. S.; Hanson, L. H.; Stevens, D. A. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob. Agents Chemother. 1992, 36 (2), 477-480.
11. Pederson, M. Isolation and antimycotic effect of a genuine miconazole-beta-cyclodextrin complex. Eur. J. Pharm. Biopharm. 1994, 40 (1), 19-23.
12. Piel, G.; Evrard, B.; Delattre, L. Multicomponent complexes of miconazole with different acids and cyclodextrins. J. Pharm. Belg. 1997, 52 (3), 124.
13. Piel, G.; Fillet, M.; Evrard, B.; Crommen, J.; Delattre, L. Comparison of the binding constant values of complexes of different antimycotic imidazole derivatives with cyclodextrin obtained by capillary electrophoresis and phase solubility diagram. Conference on Pharmaceutical Application of Cyclodextrins; Lawrence, Kansas, June 29-July 2, 1997.
14. Van Doorne, H.; Bosch, E. H.; Lerk, C. F. Formation and antimicrobial activity of complexes of beta-cyclodextrin and some antimycotic imidazole derivatives. Pharm. Weekbl. Sci. Ed. 1988, 10, 80-85.
15. Van Doorne H.; Bosch E. H.; Lerk, C. F. Interaction between cyclodextrins and some antimycotic imidazole derivatives: Studies on solubility and antimicrobial activity. In Proceedings of the Fourth International Symposium on Cyclodextrins, Huber, O., Szejtli, J., Eds.; Kluwer Academic Publishers: Dordrecht, 1988; pp 285-291.
16. Martin, A. N. In Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences, 4th ed.; Martin, A., Bustamante, P., Chun, A. H. C., Eds.; Lea & Febiger: Philadelphia, 1993; pp 257-260.
17. Szejtli, J. In Cyclodextrins Technology. Szejtli, J. Ed.; Kluwer Academic Publishers: Dordrecht, 1988; pp 186-293.
18. Pederson, M.; Edelsten, M.; Nielsen, V. F.; Scarpellini, A.; Skytte, S.; Slot, C. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. 1993, 90, 247-254.
19. El-Arini, S. K.; Leuenberger, H. Dissolution properties of praziquantel-β-cyclodextrin Systems. Pharm. Dev. Technol. 1996, 1 (3), 307-315.
20. Bender, M. L.; Komiyama, M. In Cyclodextrin Chemistry; Springer-Verlag: Berlin, 1978; pp 28-32.
21. Irie, T.; Fuganaka, K.; Pitha, J. Hydroxypropylcyclodextrins in parenteral uses. I. Lipid dissolution and effects on lipid transfer in vitro. J. Pharm. Sci. 1992, 81, 521-523.
22. Sternson, L. A.;Patton, T. F.; King, T. B. High performance liquid chromatographic analysis of miconazole in plasma. J. Chromatog. 1982, 227, 223-228.
23. Higuchi, T.; Connors, A. Phase-Solubility Techniques. In Advances in Analytical Chemistry Instrumentation, Wiley-Interscience: New York, 1965; Vol. 4, pp 117-211.
24. Wood, J.; Syarto, J.; Letterman, H. Improved holder for intrinsic dissolution rate studies. J. Pharm. Sci. 1965, 54, 1068-1070.
25. Lee, B. J.; Lee, J. R. Enhancement of solubility and dissolution rate of poorly water-soluble naproxen by complexation with 2-hydroxypropyl-β-cyclodextrin. Arch. Pharm. Res. 1995, 18 (1), 22-26.
26. Tenjarla, S. N.; Allen, R.; Borazani, A. Evaluation of verapamil hydrochloride permeation through human cadaver skin. Drug Dev. Ind. Pharm. 1994, 20, 59-63.
27. Tenjarla, S. N.; Allen, R.; Mitchell, B. High performance liquid chromatographic assay of terbutaline for preformulation studies. J. Liq. Chromatogy. 1995, 18 (8), 1603-1615.
28. Franz, T. J.; Tojo, K.; Shah, K. R.; Kydonieus, A. Transdermal delivery. In Treatise on Controlled Drug Delivery: Fundamentals, Optimization, Applications; Kydonieus, A., Eds.; Marcel Dekker Inc.: New York, 1991; pp 341-415.